Similar articles

• A perspective on dose-intensive therapy with autologous bone marrow transplantation for solid tumors.

  Ayash LJ, Antman K, Cheson BD. Ayash LJ, et al. Oncology (Williston Park). 1991 Mar;5(3):25-33; discussion 33, 36, 41. Oncology (Williston Park). 1991. PMID: 1829944 Review.
• Dose intensity studies in breast cancer--autologous bone marrow transplantation.

  Hortobagyi GN, Dunphy F, Buzdar AU, Spitzer G. Hortobagyi GN, et al. Prog Clin Biol Res. 1990;354B:195-209. Prog Clin Biol Res. 1990. PMID: 2236166 Review. No abstract available.
• The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.

  Peters WP, Ross M, Vredenburgh JJ, Hussein A, Rubin P, Dukelow K, Cavanaugh C, Beauvais R, Kasprzak S. Peters WP, et al. Semin Oncol. 1994 Aug;21(4 Suppl 7):25-31. Semin Oncol. 1994. PMID: 7916487
• High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.

  Eder JP, Antman K, Peters W, Henner WD, Elias A, Shea T, Schryber S, Andersen J, Come S, Schnipper L, et al. Eder JP, et al. J Clin Oncol. 1986 Nov;4(11):1592-7. doi: 10.1200/JCO.1986.4.11.1592. J Clin Oncol. 1986. PMID: 3534155
• Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer.

  Mulder NH, Dolsma WV, Mulder PO, De Vries EG, Willemse PH, Sleijfer DT, Hospers GA, Van der Graaf WT. Mulder NH, et al. Anticancer Res. 1995 Jul-Aug;15(4):1565-8. Anticancer Res. 1995. PMID: 7654046 Clinical Trial.